One study was a 52-week trial of aripiprazole once-monthly 400mg versus placebo ; the other was a 38-week trial of aripiprazole once-monthly 400mg , oral aripiprazole ( 10-30 mg daily ) , and aripiprazole once-monthly 50mg ( subtherapeutic dose to test assay sensitivity ) .